{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:21:41Z","timestamp":1793924501528,"version":"4.8.0"},"reference-count":153,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jid.2024.06.1295","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T15:24:54Z","timestamp":1740669894000},"page":"1589-1603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Diagnosing and Managing Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017\u20132023"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5383-7096","authenticated-orcid":false,"given":"Saskia","family":"Ingen-Housz-Oro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0627-3181","authenticated-orcid":false,"given":"Ilaria","family":"Matei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0742-2348","authenticated-orcid":false,"given":"Antoine","family":"Gaillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8592-3810","authenticated-orcid":false,"given":"Julie","family":"Gueudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6828-2411","authenticated-orcid":false,"given":"Karim","family":"Zaghbib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0465-1241","authenticated-orcid":false,"given":"Haudrey","family":"Assier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8194-457X","authenticated-orcid":false,"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4833-4320","authenticated-orcid":false,"given":"Nicolas","family":"de Prost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Bensaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachida","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9phine","family":"Redlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Courtois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Chazelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Sbidian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Nakad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Bequignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narimane","family":"Terkmane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rick","family":"Gaultier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Schlemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giao","family":"Do-Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Barbaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Lebrun-Vignes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Joachim","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Le Floch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Vabres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Delcampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"T\u00e9tart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Staumont-Sall\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Dezoteux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Misery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claire","family":"Bursztejn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dereure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Amazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Le Bidre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Le Pallec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Lagier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Ferrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2024.06.1295_bib1","doi-asserted-by":"crossref","first-page":"e456","DOI":"10.1111\/jdv.18845","article-title":"Epidermal necrolysis after COVID-19 vaccination: an exploratory analysis using World Health Organization VigiBase","volume":"37","author":"Ahouach","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.06.1295_bib2","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jaad.2022.01.039","article-title":"Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis in a cohort of patients","volume":"86","author":"Ao","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jamadermatol.2014.4844","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: ear, nose, and throat description at acute stage and after remission","volume":"151","author":"Bequignon","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib5","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/bjd.21009","article-title":"Epidermal necrolysis: characterization of different phenotypes using an unsupervised clustering analysis","volume":"186","author":"Bettuzzi","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib6","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jaad.2020.10.091","article-title":"Changing spectrum of suspected drugs of Epidermal necrolysis: a World Health Organization pharmacovigilance database analysis from 1997-2020","volume":"85","author":"Bettuzzi","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/pds.5399","article-title":"Biases associated with epidermal necrolysis reporting in pharmacovigilance: an exploratory analysis using World Health Organization VigiBase","volume":"31","author":"Bettuzzi","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jid.2024.06.1295_bib8","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1111\/jdv.18578","article-title":"Novel inflammatory markers and in-hospital mortality in epidermal necrolysis-a monocentric study of 137 patients","volume":"37","author":"Bettuzzi","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.06.1295_bib9","first-page":"247","article-title":"Trends in mortality rates for Stevens-Johnson syndrome and toxic epidermal necrolysis: experience of a single centre in France between 1997 and 2017","volume":"182","author":"Bettuzzi","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.burns.2019.09.006","article-title":"Upper airway involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"46","author":"Bhullar","year":"2020","journal-title":"Burns"},{"key":"10.1016\/j.jid.2024.06.1295_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13256-022-03502-8","article-title":"Transplantation of autologous cultivated oral mucosal epithelial sheets for limbal stem cell deficiency at Siriraj Hospital: a case series","volume":"16","author":"Booranapong","year":"2022","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jid.2024.06.1295_bib12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/bjd.19893","article-title":"Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus","volume":"185","author":"Br\u00fcggen","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bjps.2019.07.015","article-title":"Toxic epidermal necrolysis (TEN): acute complications and long-term sequelae management in a multidisciplinary follow-up","volume":"73","author":"Caba\u00f1as Weisz","year":"2020","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jid.2024.06.1295_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jaad.2014.06.026","article-title":"Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review","volume":"72","author":"Canavan","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/ICL.0000000000000986","article-title":"Sutureless amniotic membrane transplantation using pediatric nasogastric tube for patients with acute Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"49","author":"Ceylan","year":"2023","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jid.2024.06.1295_bib16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/bjd.18424","article-title":"Incidence of and mortality from epidermal necrolysis (Stevens-Johnson syndrome\/toxic epidermal necrolysis) in France during 2003\u201316: a four-source capture-recapture estimate","volume":"182","author":"Chaby","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib17","first-page":"329","article-title":"Severe cutaneous adverse reactions due to inappropriate medication use","volume":"179","author":"Chaby","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib18","doi-asserted-by":"crossref","DOI":"10.5070\/D3241037941","article-title":"Vaccine-induced toxic epidermal necrolysis: a case and systematic review","volume":"24","author":"Chahal","year":"2018","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jid.2024.06.1295_bib19","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.jaad.2020.08.065","article-title":"Disseminated intravascular coagulation in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"84","author":"Chen","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2147\/CMAR.S163391","article-title":"Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies","volume":"10","author":"Chen","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.jid.2024.06.1295_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/tjo.tjo_16_21","article-title":"Update on the application of amniotic membrane in immune-related ocular surface diseases","volume":"11","author":"Chen","year":"2021","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/biomedicines11010177","article-title":"Delayed drug hypersensitivity reactions: molecular recognition, genetic susceptibility, and immune mediators","volume":"11","author":"Chu","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jid.2024.06.1295_bib23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jid.2024.06.1295_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jdin.2021.03.008","article-title":"Delayed admission to a specialist referral center for Stevens-Johnson syndrome and toxic epidermal necrolysis is associated with increased mortality: a retrospective cohort study","volume":"4","author":"Clark","year":"2021","journal-title":"JAAD Int"},{"key":"10.1016\/j.jid.2024.06.1295_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdin.2023.01.012","article-title":"Physical and mental health impact of Stevens-Johnson syndrome\/toxic epidermal necrolysis and post-hospital discharge care: identifying practice gaps","volume":"11","author":"Coromilas","year":"2023","journal-title":"JAAD Int"},{"key":"10.1016\/j.jid.2024.06.1295_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/CCM.0b013e31829eb94f","article-title":"Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation","volume":"42","author":"de Prost","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jid.2024.06.1295_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/bjd.14799","article-title":"Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"175","author":"Dodiuk-Gad","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib28","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1111\/jdv.14935","article-title":"Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that \u2018toxic\u2019 epidermal necrolysis can be \u2018non-toxic\u2019","volume":"32","author":"Dumas","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.06.1295_bib29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/bjd.13505","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: follow-up of pulmonary function after remission","volume":"172","author":"Duong","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib30","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2024.06.1295_bib31","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jid.2024.06.1295_bib32","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/bcp.13827","article-title":"Drug-induced linear immunoglobulin A bullous dermatosis: a French retrospective pharmacovigilance study of 69 cases","volume":"85","author":"Garel","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jid.2024.06.1295_bib33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/bjd.20775","article-title":"Lupus erythematosus and epidermal necrolysis: a case series of 16 patients","volume":"186","author":"Gaudin","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib34","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/archdermatol.2009.233","article-title":"Severe and unrecognized dental abnormalities after drug-induced epidermal necrolysis","volume":"145","author":"Gaultier","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib35","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/bjd.17428","article-title":"Gastrointestinal involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective case series","volume":"180","author":"Gendreau","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib36","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1111\/jdv.18550","article-title":"Store and forward Teledermatology for epidermal necrolysis management: experience of a French reference centre","volume":"37","author":"Giraud-Kerleroux","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.06.1295_bib37","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jid.2017.05.022","article-title":"Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches","volume":"137","author":"Gonz\u00e1lez-Herrada","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jtos.2023.01.008","article-title":"Managing chronic inflammation in ocular sequelae of Stevens Johnson Syndrome to restore vision","volume":"28","author":"Gupta","year":"2023","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jid.2024.06.1295_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jtos.2020.05.003","article-title":"The effects of systemic cyclosporine in acute Stevens-Johnson syndrome\/toxic epidermal necrolysis on ocular disease","volume":"19","author":"Hall","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jid.2024.06.1295_bib40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaad.2021.08.051","article-title":"Medical management of Stevens-Johnson syndrome\/toxic epidermal necrolysis among North American dermatologists","volume":"87","author":"Han","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib41","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/bjd.17267","article-title":"Post-traumatic stress disorder in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients","volume":"180","author":"Hefez","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jamadermatol.2021.1136","article-title":"Long-term physical and psychological outcomes of Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"157","author":"Hoffman","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib43","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/ICO.0b013e31823d02a8","article-title":"Indications and outcomes of amniotic membrane transplantation in the management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study","volume":"31","author":"Hsu","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jid.2024.06.1295_bib44","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-b\u22175801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2024.06.1295_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ajo.2022.05.015","article-title":"Osteo-odonto-keratoprosthesis according to Strampelli original technique: a retrospective study with up to 30 years of follow-up","volume":"242","author":"Iannetti","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib46","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/bjd.18387","article-title":"Health-related quality of life and long-term sequelae in survivors of epidermal necrolysis: an observational study of 57 patients","volume":"182","author":"Ingen-Housz-Oro","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib47","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jamadermatol.2022.6262","article-title":"Outcomes associated with neutropenia and lymphopenia in epidermal necrolysis: a single-center retrospective study of 147 patients","volume":"159","author":"Ingen-Housz-Oro","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13023-018-0793-7","article-title":"Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)","volume":"13","author":"Ingen-Housz-Oro","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2024.06.1295_bib49","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1111\/jdv.16884","article-title":"Carrying out local care for epidermal necrolysis: survey of practices","volume":"35","author":"Ingen-Housz-Oro","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.06.1295_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.annder.2024.103282","article-title":"French national protocol for diagnosis and management of epidermal necrolysis in adults (Stevens-Johnson syndrome and toxic epidermal necrolysis)","volume":"151","author":"Ingen-Housz-Oro","year":"2024","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.06.1295_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/CMR.0000000000000819","article-title":"Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases","volume":"32","author":"Ingen-Housz-Oro","year":"2022","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2024.06.1295_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13023-023-02631-7","article-title":"Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus","volume":"18","author":"Ingen-Housz-Oro","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2024.06.1295_bib53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jtos.2018.08.003","article-title":"Boston Type 2 keratoprosthesis- mid term outcomes from a tertiary eye care centre in India","volume":"17","author":"Iyer","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jid.2024.06.1295_bib54","first-page":"CD013130","article-title":"Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS\/TEN overlap syndrome","volume":"3","author":"Jacobsen","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jid.2024.06.1295_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4253\/wjge.v11.i2.115","article-title":"Spectrum of gastrointestinal involvement in Stevens - Johnson syndrome","volume":"11","author":"Jha","year":"2019","journal-title":"World J Gastrointest Endosc"},{"key":"10.1016\/j.jid.2024.06.1295_bib56","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1346-8138.2006.00142.x","article-title":"Chronic pulmonary complications associated with toxic epidermal necrolysis: report of a severe case with anti-Ro\/SS-A and a review of the published work","volume":"33","author":"Kamada","year":"2006","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib57","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.clnu.2023.04.006","article-title":"Nutritional and metabolic characteristics of critically ill patients admitted for severe toxidermia","volume":"42","author":"Karakus","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jid.2024.06.1295_bib58","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jaad.2018.06.002","article-title":"Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"79","author":"Kim","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib59","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/s41598-020-60794-w","article-title":"Comparison of the ocular microbiome between chronic Stevens-Johnson syndrome patients and healthy subjects","volume":"10","author":"Kittipibul","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2024.06.1295_bib60","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jaad.2019.05.096","article-title":"Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: a cohort study of 176 patients","volume":"81","author":"Koh","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib61","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jamadermatol.2020.3654","article-title":"Assessment and comparison of performance of ABCD-10 and SCORTEN in prognostication of epidermal necrolysis","volume":"156","author":"Koh","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib62","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jamadermatol.2021.5119","article-title":"Improvement of mortality prognostication in patients with epidermal necrolysis: the role of novel inflammatory markers and proposed revision of SCORTEN (Re-SCORTEN)","volume":"158","author":"Koh","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib63","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.burns.2021.11.004","article-title":"Impact of multiple medical interventions on mortality, length of hospital stay and reepithelialization time in toxic epidermal necrolysis, Steven-Johnsons Syndrome, and TEN\/SJS Overlap - Metanalysis and metaregression of observational studies","volume":"48","author":"Krajewski","year":"2022","journal-title":"Burns"},{"key":"10.1016\/j.jid.2024.06.1295_bib64","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jamadermatol.2021.3154","article-title":"Assessment of treatment approaches and outcomes in Stevens-Johnson syndrome and toxic epidermal necrolysis: insights from a Pan-European multicenter study","volume":"157","author":"Kridin","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib65","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkaa041","article-title":"Acute lung injury in mechanically ventilated patients with epidermal necrolysis: an exposed-unexposed retrospective cohort study","volume":"8","author":"Lalev\u00e9e","year":"2020","journal-title":"Burns Trauma"},{"key":"10.1016\/j.jid.2024.06.1295_bib66","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaad.2019.03.030","article-title":"Incidence of bloodstream infections and predictive value of qualitative and quantitative skin cultures of patients with overlap syndrome or toxic epidermal necrolysis: a retrospective observational cohort study of 98 cases","volume":"81","author":"Lecadet","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib67","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2016.07.048","article-title":"Cyclosporine treatment for Stevens-Johnson syndrome\/toxic epidermal necrolysis: retrospective analysis of a cohort treated in a specialized referral center","volume":"76","author":"Lee","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib68","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/bjd.15360","article-title":"Long-term complications of Stevens-Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN): the spectrum of chronic problems in patients who survive an episode of SJS\/TEN necessitates multidisciplinary follow-up","volume":"177","author":"Lee","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib69","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ijd.15888","article-title":"Managing respiratory complications in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"61","author":"Lee","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib70","article-title":"The influence of acute kidney injury on the outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis: the prognostic value of KDIGO staging","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2024.06.1295_bib71","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.burns.2018.01.019","article-title":"Toxic epidermal necrolysis data from the Celeste multinational registry. Part I: epidemiology and general microbiological characteristics","volume":"44","author":"Lipov\u00fd","year":"2018","journal-title":"Burns"},{"key":"10.1016\/j.jid.2024.06.1295_bib72","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.burns.2018.03.006","article-title":"Toxic epidermal necrolysis data from the Celeste multinational registry. Part II: specific systemic and local risk factors for the development of infectious complications","volume":"44","author":"Lipov\u00fd","year":"2018","journal-title":"Burns"},{"key":"10.1016\/j.jid.2024.06.1295_bib73","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1111\/ijd.14811","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis-like reactions to checkpoint inhibitors: a systematic review","volume":"59","author":"Maloney","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib74","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2147\/OPTH.S299141","article-title":"Management of persistent corneal epithelial defects with human amniotic membrane-derived dry matrix","volume":"15","author":"Maqsood","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib75","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1111\/jdv.17698","article-title":"Stevens-Johnson syndrome\/toxic epidermal necrolysis-like cutaneous lupus erythematosus. A case series with long-term follow-up","volume":"36","author":"Marti-Marti","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.06.1295_bib76","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajo.2023.05.010","article-title":"Topical betamethasone treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular involvement in the acute phase","volume":"253","author":"Matsumoto","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib77","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamadermatol.2017.0160","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis standard reporting and evaluation guidelines: results of a National Institutes of Health working group","volume":"153","author":"Maverakis","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib78","first-page":"153","article-title":"Vulvovaginal sequelae in toxic epidermal necrolysis","volume":"42","author":"Meneux","year":"1997","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jid.2024.06.1295_bib79","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.jid.2018.04.027","article-title":"Stevens-Johnson syndrome\/toxic epidermal necrolysis: a multicenter retrospective study of 377 adult patients from the United States","volume":"138","author":"Micheletti","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib80","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajo.2021.06.015","article-title":"Corticosteroid pulse therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis patients with acute ocular involvement","volume":"231","author":"Mieno","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jtos.2022.11.002","article-title":"Outcomes of keratolimbal allograft from ABO compatible donors for severe bilateral limbal stem cell deficiency","volume":"27","author":"Mimouni","year":"2023","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jid.2024.06.1295_bib82","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/11206721211011354","article-title":"Sutureless dehydrated amniotic membrane for persistent epithelial defects","volume":"32","author":"Mimouni","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib83","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/jdv.17274","article-title":"Towards a better understanding of adult idiopathic epidermal necrolysis: a retrospective study of 19 cases","volume":"35","author":"Monnet","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.06.1295_bib84","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.burns.2017.09.015","article-title":"Improving mortality outcomes of Stevens Johnson syndrome\/toxic epidermal necrolysis: a regional burns centre experience","volume":"44","author":"Nizamoglu","year":"2018","journal-title":"Burns"},{"key":"10.1016\/j.jid.2024.06.1295_bib85","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jaad.2019.05.020","article-title":"Timing of mucocutaneous symptoms and medication discontinuation in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States","volume":"81","author":"Noe","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib86","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.jid.2018.03.1496","article-title":"Selective use of cyclosporine for Stevens-Johnson syndrome\/toxic epidermal necrolysis may exclude patients with poor prognostic factors","volume":"138","author":"Noe","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib87","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/jamadermatol.2018.5605","article-title":"Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis-ABCD-10","volume":"155","author":"Noe","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib88","first-page":"CD011821","article-title":"Antiseptics for burns","volume":"7","author":"Norman","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jid.2024.06.1295_bib89","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.anai.2023.01.006","article-title":"Drug patch testing in Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review","volume":"130","author":"Novack","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jid.2024.06.1295_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270424","article-title":"Psychotherapeutic interventions for burns patients and the potential use with Stevens-Johnson syndrome and toxic epidermal necrolysis patients: a systematic integrative review","volume":"17","author":"O\u2019Reilly","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2024.06.1295_bib91","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1111\/jdv.16958","article-title":"Patients\u2019, family members\u2019 and healthcare practitioners\u2019 experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis: a qualitative descriptive study using emotional touchpoints","volume":"35","author":"O\u2019Reilly","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.06.1295_bib92","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/SCS.0000000000004584","article-title":"Management of severe cicatricial entropion with labial mucous membrane graft in cicatricial ocular surface disorders","volume":"29","author":"Osaki","year":"2018","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.jid.2024.06.1295_bib93","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BCR.0000000000000601","article-title":"Prone positioning of the burn patient with acute respiratory distress syndrome: a review of the evidence and practical considerations","volume":"39","author":"Oto","year":"2018","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.jid.2024.06.1295_bib94","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/bjd.14934","article-title":"Renal replacement therapy during Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patients","volume":"176","author":"Papo","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib95","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1684\/ejd.2020.3883","article-title":"A new case series on etanercept treatment for toxic epidermal necrolysis","volume":"30","author":"Paradisi","year":"2020","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib96","doi-asserted-by":"crossref","first-page":"207","DOI":"10.23822\/EurAnnACI.1764-1489.193","article-title":"Severe cutaneous adverse drug reactions: diagnostic approach and genetic study in a Brazilian case series","volume":"54","author":"Perell\u00f3","year":"2022","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2024.06.1295_bib97","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1684\/ejd.2021.4051","article-title":"Clinical and histological features of fixed drug eruption: a single-centre series of 73 cases with comparison between bullous and non-bullous forms","volume":"31","author":"Perron","year":"2021","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib98","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2147\/PPA.S285256","article-title":"Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson syndrome (SJS) and\/or toxic epidermal necrolysis (TEN) Patients","volume":"15","author":"Perwitasari","year":"2021","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jid.2024.06.1295_bib99","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/09546634.2020.1770173","article-title":"Ventilatory support in Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"33","author":"Phan","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jid.2024.06.1295_bib100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2018.10.030","article-title":"Controversies in drug allergy: testing for delayed reactions","volume":"143","author":"Phillips","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2024.06.1295_bib101","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jamadermatol.2022.0484","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis-coordinating research priorities to move the field forward","volume":"158","author":"Phillips","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib102","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00005373-197101000-00003","article-title":"Hemodynamic changes in the early postburn patient: the influence of fluid administration and of a vasodilator (hydralazine)","volume":"11","author":"Pruitt","year":"1971","journal-title":"J Trauma"},{"key":"10.1016\/j.jid.2024.06.1295_bib103","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/s41433-020-01203-4","article-title":"Mucous membrane grafting (fibrin glue vs. suture) for lid margin pathologies in Stevens-Johnson syndrome: randomized comparative study","volume":"35","author":"Pushker","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jid.2024.06.1295_bib104","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/ddg.13876","article-title":"Severe bullous skin eruptions on checkpoint inhibitor therapy - in most cases severe bullous lichenoid drug eruptions","volume":"17","author":"Reschke","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jid.2024.06.1295_bib105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00228-018-2569-3","article-title":"Incidence of Stevens-Johnson syndrome\/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study","volume":"75","author":"Rodr\u00edguez-Mart\u00edn","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jid.2024.06.1295_bib106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","article-title":"Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985","volume":"126","author":"Roujeau","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib107","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archderm.1987.01660330082014","article-title":"Genetic susceptibility to toxic epidermal necrolysis","volume":"123","author":"Roujeau","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib108","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1016\/j.jaip.2022.07.008","article-title":"Skin testing and drug provocation tests in epidermal necrolysis: a French experience","volume":"10","author":"Roux","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jid.2024.06.1295_bib109","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajo.2022.06.022","article-title":"Restoration of vision in severe, cicatricial, ocular surface disease with the Boston keratoprosthesis Type II","volume":"243","author":"Saini","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jtos.2021.07.005","article-title":"A new option for treatment of severe cicatricial entropion in patients with Stevens-Johnson syndrome","volume":"22","author":"Sant\u2019Anna","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jid.2024.06.1295_bib111","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jid.2024.06.1295_bib112","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jaad.2020.02.066","article-title":"Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults","volume":"82","author":"Seminario-Vidal","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib113","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jtos.2019.03.001","article-title":"Sutureless amniotic membrane transplantation with cyanoacrylate glue for acute Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"17","author":"Shanbhag","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jid.2024.06.1295_bib114","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jtos.2020.03.004","article-title":"Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"18","author":"Shanbhag","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jid.2024.06.1295_bib115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ajo.2019.07.006","article-title":"Long-term effect of a treatment protocol for acute ocular involvement in Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"208","author":"Shanbhag","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib116","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4103\/ijo.IJO_1273_20","article-title":"A beginner\u2019s guide to mucous membrane grafting for lid margin keratinization: review of indications, surgical technique and clinical outcomes","volume":"69","author":"Shanbhag","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.992696","article-title":"Visual function and quality of life in patients with Stevens-Johnson syndrome who received acute protocol-based ocular care","volume":"4","author":"Shanbhag","year":"2022","journal-title":"Front Toxicol"},{"key":"10.1016\/j.jid.2024.06.1295_bib118","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ophtha.2015.10.027","article-title":"Adjuvant role of amniotic membrane transplantation in acute ocular Stevens-Johnson syndrome: a randomized control trial","volume":"123","author":"Sharma","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jid.2024.06.1295_bib119","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jtos.2020.06.005","article-title":"Long-term outcomes of cultivated cell sheet transplantation for treating total limbal stem cell deficiency","volume":"18","author":"Shimazaki","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jid.2024.06.1295_bib120","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/ICO.0000000000003021","article-title":"Single-staged surgical correction of eyelid sequelae along with lid margin mucous membrane grafting in Stevens-Johnson syndrome and other cicatricial ocular surface diseases","volume":"42","author":"Shree","year":"2023","journal-title":"Cornea"},{"key":"10.1016\/j.jid.2024.06.1295_bib121","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.4103\/IJO.IJO_2647_22","article-title":"5-fluorouracil as a targeted lacrimal gland therapy for chronic Stevens-Johnson syndrome: a pilot study","volume":"71","author":"Singh","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib122","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/01676830.2020.1782439","article-title":"Labial mucosa grafting for lid margin, anterior lamellar, and posterior lamellar correction in recurrent cicatricial entropion","volume":"40","author":"Singh","year":"2021","journal-title":"Orbit"},{"key":"10.1016\/j.jid.2024.06.1295_bib123","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.vaccine.2019.12.028","article-title":"Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999\u20132017","volume":"38","author":"Su","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jid.2024.06.1295_bib124","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdermsci.2022.07.004","article-title":"Risk factors for sepsis and effects of pretreatment with systemic steroid therapy for underlying condition in SJS\/TEN patients: results of a nationwide cross-sectional survey in 489 Japanese patients","volume":"107","author":"Sunaga","year":"2022","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2024.06.1295_bib125","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.2147\/OPTH.S385078","article-title":"Treatment of severe dry eye in Stevens-Johnson syndrome with umbilical cord serum eye drops","volume":"16","author":"Susiyanti","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib126","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/ced.13991","article-title":"Contrast media and cutaneous reactions. Part 2: delayed hypersensitivity reactions to iodinated contrast media","volume":"44","author":"Tasker","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib127","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000528919","article-title":"Saline vehicle increases the ability of drug patch test in cutaneous adverse drug reactions","volume":"239","author":"Thaiwat","year":"2023","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2024.06.1295_bib128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13023-023-02616-6","article-title":"Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management","volume":"18","author":"Thorel","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2024.06.1295_bib129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13023-020-01538-x","article-title":"Management of ocular involvement in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: french national audit of practices, literature review, and consensus agreement","volume":"15","author":"Thorel","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2024.06.1295_bib130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.anai.2022.05.009","article-title":"Etanercept treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"129","author":"Tian","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jid.2024.06.1295_bib131","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/cup.12894","article-title":"Microbiological findings and antibacterial therapy in Stevens-Johnson syndrome\/toxic epidermal necrolysis patients from a Swedish Burn Center","volume":"44","author":"Tocco-Tussardi","year":"2017","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jid.2024.06.1295_bib132","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1128\/JCM.00326-09","article-title":"Evaluation of five commercial real-time PCR assays for detection of Mycoplasma pneumoniae in respiratory tract specimens","volume":"47","author":"Touati","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jid.2024.06.1295_bib133","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ajo.2009.07.006","article-title":"Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"148","author":"Tougeron-Brousseau","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib134","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/bjd.18294","article-title":"Individual- and hospital-level factors associated with epidermal necrolysis mortality: a nationwide multilevel study, France, 2012-2016","volume":"182","author":"Traikia","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jaad.2020.08.122","article-title":"Treating toxic epidermal necrolysis with systemic immunomodulating therapies: a systematic review and network meta-analysis","volume":"84","author":"Tsai","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib136","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2023-254975","article-title":"Recurrent reactive infectious mucocutaneous eruption in a male adult patient associated with Mycoplasma pneumoniae, SARS-CoV-2 and rhinovirus","volume":"16","author":"van Dam","year":"2023","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jid.2024.06.1295_bib137","first-page":"438","article-title":"Guidelines and systematic reviews: sizing up guidelines in general practice","volume":"46","author":"van Driel","year":"2017","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.jid.2024.06.1295_bib138","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ajo.2020.08.022","article-title":"Outcomes of cultivated oral mucosal epithelial transplantation in eyes with chronic Stevens-Johnson syndrome sequelae","volume":"222","author":"Venugopal","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib139","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI93349","article-title":"Randomized, controlled trial of TNF-\u03b1 antagonist in CTL-mediated severe cutaneous adverse reactions","volume":"128","author":"Wang","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jid.2024.06.1295_bib140","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jtos.2021.06.005","article-title":"Long-term outcomes of the MICOF keratoprosthesis surgery","volume":"21","author":"Wang","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jid.2024.06.1295_bib141","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/jamadermatol.2022.3011","article-title":"Prevalence of leukopenia and associated outcomes in patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"158","author":"Wang","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib142","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/1346-8138.15968","article-title":"Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"48","author":"Wang","year":"2021","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2019.01.006","article-title":"Prosthetic replacement of the ocular surface ecosystem treatment for ocular surface disease in pediatric patients with Stevens-Johnson syndrome","volume":"201","author":"Wang","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib144","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jdin.2023.06.014","article-title":"Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome","volume":"13","author":"Wasuwanich","year":"2023","journal-title":"JAAD Int"},{"key":"10.1016\/j.jid.2024.06.1295_bib145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.023","article-title":"SJS\/TEN 2017: building multidisciplinary networks to drive science and translation","volume":"6","author":"White","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jid.2024.06.1295_bib146","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/jamadermatol.2020.4490","article-title":"Accuracy and cost-effectiveness of a telemedicine triage initiative for patients with suspected Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"157","author":"Wong","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.06.1295_bib147","first-page":"E15","article-title":"Tumor necrosis factor alpha inhibitors in the treatment of toxic epidermal necrolysis","volume":"101","author":"Woolridge","year":"2018","journal-title":"Cutis"},{"key":"10.1016\/j.jid.2024.06.1295_bib148","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bjophthalmol-2020-316056","article-title":"Amniotic membrane transplantation for Stevens-Johnson syndrome\/toxic epidermal necrolysis: the Toronto experience","volume":"105","author":"Yang","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib149","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jtos.2018.11.008","article-title":"Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization","volume":"17","author":"Yin","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jid.2024.06.1295_bib150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10792-017-0786-x","article-title":"Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bevacizumab for corneal neovascularization in Stevens-Johnson syndrome","volume":"39","author":"Yoon","year":"2019","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jid.2024.06.1295_bib151","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/ICL.0000000000000989","article-title":"Long-term benefits of tear exchangeable limbal-rigid contact lens wear therapy in Stevens-Johnson syndrome cases","volume":"49","author":"Yoshikawa","year":"2023","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jid.2024.06.1295_bib152","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/09546634.2019.1577548","article-title":"Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systemic review","volume":"31","author":"Zhang","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jid.2024.06.1295_bib153","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","article-title":"Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"153","author":"Zimmermann","year":"2017","journal-title":"JAMA Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25000788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25000788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:47:08Z","timestamp":1782964028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25000788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":153,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0022202X25000788"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2024.06.1295","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosing and Managing Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017\u20132023","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2024.06.1295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Investigative Dermatology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}